Adjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma.
about
Adjuvant therapy for locally advanced renal cell cancer: a systematic review with meta-analysisTumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy.Dual inhibition of BRD4 and PI3K-AKT by SF2523 suppresses human renal cell carcinoma cell growth.
P2860
Adjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adjuvant and neoadjuvant small ...... igh-risk renal cell carcinoma.
@en
Adjuvant and neoadjuvant small ...... igh-risk renal cell carcinoma.
@nl
type
label
Adjuvant and neoadjuvant small ...... igh-risk renal cell carcinoma.
@en
Adjuvant and neoadjuvant small ...... igh-risk renal cell carcinoma.
@nl
prefLabel
Adjuvant and neoadjuvant small ...... igh-risk renal cell carcinoma.
@en
Adjuvant and neoadjuvant small ...... igh-risk renal cell carcinoma.
@nl
P2093
P2860
P1433
P1476
Adjuvant and neoadjuvant small ...... high-risk renal cell carcinoma
@en
P2093
P2860
P478
16 Suppl 1
P577
2009-05-01T00:00:00Z